top of page

Home > Specialists > Integrative Oncology > Dr. Changsheng Dong (董昌盛)

Dr. Shijing Deng - Ophthalmologist - Beijing Tongren Hospital Beijing

Specialty & Clinical Focus:

Integrative Oncology specialist at Longhua Hospital in Shanghai, with a clinical focus on the holistic management of malignant tumors, symptom relief, and the integration of Traditional Chinese Medicine (TCM) with modern oncology therapies.

Professional Title & Qualifications:

  • Associate Chief Physician,

  • Associate Researcher,

  • Master's Supervisor,

  • Xinglin Young Scholar (Shanghai University of Traditional Chinese Medicine)

Hospital & Department:

Longhua Hospital, Shanghai University of Traditional Chinese Medicine – Department of Oncology (Cancer Institute of Traditional Chinese Medicine)

(address: No. 725 South Wanping Road, Xuhui District, Shanghai, 200032)

Dr. Changsheng Dong (董昌盛) - TCM Oncology Specialist

Personal Biography

Dr. Changsheng Dong is an accomplished Integrative Oncology specialist in Shanghai with over 25 years of clinical experience. He serves as an Associate Chief Physician and Associate Researcher at Longhua Hospital. Dr. Dong is dedicated to integrating classical Traditional Chinese Medicine (TCM) with modern medical technology. His patient-centric approach organically fuses TCM herbal protocols with modern Western therapies, including chemotherapy, radiotherapy, targeted therapy, and immunotherapy. As a recognized “Xinglin Young Scholar,” his clinical work focuses on comprehensive tumor management and supportive care for symptoms and quality-of-life concerns. His clinical background and peer-reviewed research may be relevant to international patients exploring integrative oncology pathways in China.

Why Consider Dr. Changsheng Dong for an Integrative Oncology Review?

Dr. Changsheng Dong brings over 25 years of clinical experience in Traditional Chinese Medicine (TCM) to his role as an Associate Chief Physician at Longhua Hospital. He focuses on combining classical TCM frameworks with modern medical treatments, including chemotherapy, radiotherapy, and immunotherapy. For international patients, this integrative methodology offers a structured approach to addressing both primary conditions and associated symptoms, such as treatment side effects and pain.


His evidence-based practice is supported by extensive academic research, including over 70 published papers and award-winning innovations in TCM oncology. Because integrative cancer care requires highly customized planning, international patients are encouraged to organize their medical records and past treatment history for a remote specialist review. This allows Dr. Dong to evaluate your specific case and outline potential therapeutic pathways, helping you make informed decisions before pursuing medical travel to Shanghai.

Pre-Travel Case Review & Specialist Liaison

Making cross-border healthcare decisions requires careful consideration, but you can securely take the first step from home. Through MedBridgeNZ, international patients can request coordination for a remote specialist-review pathway with Dr. Dong where available. This client-authorized document transfer and review process provides a valuable opportunity for the specialist to evaluate your specific medical records and clarify potential integrative oncology options before you commit to international travel.


Should your pre-travel review indicate that an onsite pathway is feasible, MedBridgeNZ’s dedicated concierge team will step in to manage the administrative requirements. We coordinate hospital appointment requests, assist with medical invitation or visa-document coordination, and provide on-the-ground non-clinical bilingual administrative support, helping you navigate the travel and healthcare logistics in Shanghai with confidence.

Disclaimer: MedBridgeNZ is a medical concierge provider serving a global client base. We assist with logistical coordination and facilitate access to healthcare professionals. MedBridgeNZ does not provide medical advice, diagnoses, or treatments.Any clinical feedback, treatment planning or suitability discussion remains with the relevant hospital or licensed specialist.

Secure a Remote Case Review with

Dr. Changsheng Dong

Areas of Expertise

  • Malignant Tumors—Integrative Management: Clinical experience relating to integrative oncology and supportive care for patients with lung cancer, pancreatic cancer, brain tumors, gastrointestinal cancers, breast cancer, gynecological cancers, urological cancers, lymphoma, leukemia, and bone cancer. Clinical suitability and treatment decisions require individual specialist assessment.

  • Symptom & Supportive Care: Clinical focus on TCM-based supportive approaches for cancer-related pain, postoperative symptoms, and side effects associated with chemotherapy or radiotherapy. Any proposed approach should be assessed alongside the patient’s existing oncology treatment plan.

  • Benign Conditions: Non-surgical management of thyroid/breast nodules, cysts, and uterine fibroids using Chinese medicine.

  • General Health & Chronic Diseases: Treatment of intractable insomnia, pulmonary fibrosis, chronic cough, and male health issues, utilizing a holistic TCM approach.

  • Therapeutic Techniques: Expert application of Chinese herbal medicine, Acupuncture, Moxibustion, Tuina (manipulation), and Cupping therapy.

Verified Client Satisfaction Metrics

⭐⭐⭐⭐⭐ 5.0/5.0 Overall Rating

* Treatment Pathway Satisfaction:

5.0/5.0

* Communication & Professionalism:

5.0/5.0

* High demand: Chosen online for specialist liaison and case reviews by over:

600 clients

(Source: These third-party platform indicators are provided for general reference only. They may change over time and should not be interpreted as a guarantee of diagnosis, treatment suitability, appointment availability, or individual clinical outcome.)

Work Experience

  • Current: Associate Chief Physician & Associate Researcher, Department of Oncology, Longhua Hospital.

  • Academic: Master's Supervisor, Shanghai University of Traditional Chinese Medicine.

  • Research Leadership: Hosted 6 research projects and participated in 16 national and international scientific research initiatives.

  • Clinical Heritage: Over 25 years of dedication to the study and practice of Traditional Chinese Medicine.

Education & Training

Awards & Honors

  • 2023: First Clinical Medicine Award — Young Physician Struggle Award.

  • 2019: First Prize, Shanghai Science and Technology Progress Award (Project: "Fuzheng Anticancer" Technology Innovation).

  • 2020: Recognized as an "Outstanding 'Anti-Epidemic' Young Physician Research Star."

Academic & Professional Memberships

  • Secretary General, Difficult Miscellaneous Diseases Branch, China Association for Promotion of Traditional Chinese Medicine Research.

  • Member, National Paste Prescription Anti-cancer Expert Committee.

  • Council Member, Tumor Innovation Alliance, China Association of Chinese Medicine.

  • Senior Lecturer, Shanghai Health Popularization Training Faculty Bank.

Research & Publications

  • Publication Record: Published over 70 academic papers, including 21 SCI-indexed articles, with research covering TCM oncology, cancer-related symptom management, and integrative cancer care.

  • Innovation: Holds 3 authorized patents and multiple software copyrights related to medical technology.

  • Expert Consensus: Co-authored the 2023 "Chinese Expert Consensus on Diagnosis and Treatment of Breast Cancer Postoperative Lymphedema with Integrated Traditional Chinese and Western Medicine."

Selected Peer-Reviewed Publications

Below is a selection of peer-reviewed publications co-authored by Dr. Dong, covering cancer-related pain, pancreatic cancer immunology, and preclinical bone cancer pain research:

  • Ruixin WU, et al. (2024). A pilot study of precision treatment for patients with lung cancer pain by Longteng Tongluo recipe using serum genomics. J Tradit Chin Med. 👉 Read on PubMed (PMID: 39380232)

  • Zhang J, et al. (2025). Unveiling purine metabolism dysregulation orchestrated immunosuppression in advanced pancreatic cancer and concentrating on the central role of NT5E. Front Immunol. 👉 Read on PubMed (PMID: 40236698)

  • Dong C, et al. (2016). Evaluation of Bone Cancer Pain Induced by Different Doses of Walker 256 Mammary Gland Carcinoma Cells. Pain Physician. 👉 Read on PubMed (PMID: 27676678)

*The doctor’s information is sourced from the hospital’s official website or provided directly by the doctor. Due to update cycles, there may be occasional delays in reflecting the most recent changes.

Frequently Asked Questions (FAQs)

Is Dr. Dong’s integrative oncology approach suitable for my specific diagnosis?


Dr. Dong specializes in creating personalized treatment plans for a broad spectrum of malignant tumors. To determine if his specific methodologies align with your current health status, we highly recommend organizing your medical records for a remote specialist review. MedBridgeNZ can coordinate the translation and transfer of your documents, allowing the specialist to evaluate your case and help clarify administrative and travel feasibility before an in-person pathway is pursued.


How can I request appointment coordination with Dr. Dong as an international patient?


Navigating cross-border healthcare can be complex, but MedBridgeNZ is designed to manage the logistical process on your behalf. You can begin by contacting our team to request remote specialist-review coordination. If you and the specialist decide to proceed with an onsite visit in Shanghai, our concierge service will assist with hospital appointment scheduling where available, provide medical invitation or visa-document coordination support, and offer non-clinical bilingual administrative support throughout your stay.


Can Dr. Dong help manage the side effects of my current treatments?


Potentially, depending on your diagnosis, current treatment plan, medications, and overall health. Dr. Dong’s practice includes TCM-based supportive approaches for symptoms and treatment-related side effects. Whether any approach is appropriate must be determined by the relevant licensed specialist in coordination with your treating oncology team. These approaches should not replace or delay recommended cancer treatment. MedBridgeNZ can coordinate a remote specialist review but does not determine clinical suitability or provide medical advice.

Flexible Ways to Connect with the Specialist

We understand that every client’s situation is unique. Beyond the Remote Written Review, we offer a range of flexible ways to access specialist insights:

  • Remote Video Liaison: For a more personal interaction, we can arrange a live video session, allowing you to discuss your case directly with the specialist with the help of our professional medical translators.

  • On-Site Proxy Liaison: If you cannot travel, our dedicated bilingual team can visit the hospital in person on your behalf. We will present your translated medical records to the specialist, facilitate your inquiries, and provide you with a comprehensive translated report of the doctor’s findings.

  • In-Person Appointment Booking: If you are planning to travel to China for treatment, we manage the complex hospital registration and appointment process, ensuring you have confirmed access to your chosen specialist upon arrival.

How MedBridgeNZ Helps You:

MedBridgeNZ is a medical concierge and logistics coordination provider for international patients seeking specialist-care pathways in China. We assist with appointment request coordination, medical-record preparation, translation coordination, medical invitation or visa-document support, travel planning, and non-clinical bilingual administrative support. We do not provide medical advice, diagnosis, or treatment, and third-party medical or travel costs remain separate unless expressly stated in writing.

bottom of page